Literature DB >> 31427077

[Adaptive radiotherapy: Strategies and benefits depending on tumor localization].

A Briens1, J Castelli2, A Barateau2, N Jaksic1, K Gnep1, A Simon3, R De Crevoisier4.   

Abstract

Adaptive radiotherapy (ART) is a complexe image-guided radiotherapy modality that comprises multiple planning to account for anatomical variations occurring during irradiation. Schematically, two strategies of RTA can be distinguished and combined according to tumor locations. One or more replanning can be proposed to correct systematic variations such as tumor shrinkage. A library of treatment plans with day-to-day plan selection from cone-beam CT imaging can also be proposed to correct random variations such as uterine motion or bladder/rectum volume changes. Because of strong anatomical variations occurring during irradiation, RTA appears therefore particularly justified in head and neck, lung, bladder, cervical and rectum and pancreas tumors, and to a lesser extent for prostate tumors and other digestive tumors. For these tumor locations, ART provides a fairly clear dosimetric benefit but a clinical benefit not yet formally demonstrated. ART cannot be proposed in a routine practice but must be evaluated medico-economically in the context of prospective trials. A rigorous quality control must be associated.
Copyright © 2019 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adaptive radiotherapy; Image guided radiotherapy; Radiothérapie adaptative; Radiothérapie guidée par l’image

Mesh:

Year:  2019        PMID: 31427077     DOI: 10.1016/j.canrad.2019.07.135

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  2 in total

1.  Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus.

Authors:  Sujing Zhang; Li He; Changwen Bo; Shufang Yang; Yonghui An; Na Li; Yingchun Zhao; Liping Zhao; Wenhua Ma; Zheng Zheng
Journal:  Radiat Oncol       Date:  2021-08-14       Impact factor: 3.481

Review 2.  Radiomics for radiation oncologists: are we ready to go?

Authors:  Loïg Vaugier; Ludovic Ferrer; Laurence Mengue; Emmanuel Jouglar
Journal:  BJR Open       Date:  2020-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.